Lancet Experts Assess Whether Global Viral Hepatitis Elimination by 2030 Remains Achievable
Start here
A Lancet expert discussion has reviewed the feasibility of eliminating viral hepatitis worldwide by 2030, a goal confronting an infected population of roughly 287 million people. The tools are largely in place: hepatitis B vaccination since the early 1980s has averted an estimated 22 million child deaths since 1990, and hepatitis C is now curable in about 95% of cases with two to three months of daily oral therapy costing under $200 in low- and middle-income countries, a sharp drop from earlier prices. The central obstacles are low testing and diagnosis rates, with only about 10% of hepatitis B patients diagnosed. Whether the 2030 target can be met depends on closing that diagnostic gap at scale.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- youtube.comThe Lancet Experts Weigh Whether Global Viral Hepatitis Elimination by 2030 Is Achievable
A Lancet expert discussion reviews prospects for eliminating viral hepatitis, which infects about 287 million people worldwide. Hepatitis B vaccination since the early 1980s has averted an estimated 22 million child deaths since 1990, and hepatitis C is now curable in about 95% of cases with 2 to 3 months of daily oral therapy costing under $200 in low- and middle-income countries, down sharply from earlier prices. The main barriers to the 2030 elimination goal are low testing and diagnosis rates, with only about 10% of hepatitis B patients diagnosed.
Heat trend for this story
Heat now 9·Peak in the comparable set 10 (Oct 18 04:00)·Change over 24h in the comparable set –
The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's heat; the left and right arrow keys work too.